GREGG FRIESEN: Open Payments
NPI 1184608291 · NEWTON, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$217 in 10 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $52 · 2025 $217
Food & beverage: $217
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $54 |
| Janssen Pharmaceuticals, Inc | 2 | $52 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Noven Therapeutics, LLC | 1 | $19 |
| Alkermes, Inc. | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
Products named: UZEDY, INVEGA SUSTENNA, SPRAVATO, Auvelity, AUSTEDO XR, Xelstrym, REXULTI, ARISTADA.
Industry payments across KS — which companies pay providers there.
